Gritstone bio, Inc.
Gritstone bio, Inc. (GRTS) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · GRTS · as of Jun 9, 2026
Key Statistics
Explore Gritstone bio, Inc. Data
grts stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 13 · Buy rate: 53.8%
The GRTS analyst consensus is Buy, based on ratings from 13 Wall Street analysts over the past 3 months. The average 12-month price target is $4.67, representing +14403.11% upside from the current price of $0.03.
Competitors & Peers
grts competitorsGRTS
AFMD
APTO
BCEL
GMDA
IDRAStock Performance
Full HistoryAbout Gritstone bio, Inc.
Gritstone bio, Inc. is a clinical-stage biotechnology company focused on pioneering immunotherapies to address various types of cancer and infectious diseases. Its primary product candidate, GRANITE, …
what is gritstone bio, inc. · grts stock overview · gritstone bio, inc. company profile · who is gritstone bio, inc. ceo · grts NASDAQ · gritstone bio, inc. headquarters · gritstone bio, inc. business segments
About Stock Overview & Key Data
Gritstone bio, Inc. (GRTS) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Sep 28, 2018. As of the latest trading session, GRTS stock price is $0.03, with a market capitalization of $3.8M. The stock has returned -97.56% over the past 12 months and -98.52% year-to-date.
According to 13 Wall Street analysts, the consensus rating for Gritstone bio, Inc. stock is Buy, with an average 12-month price target of $4.67. In fiscal year 2023, Gritstone bio, Inc. reported revenue of $1.3M and net income of -$138.5M. For detailed data — including Gritstone bio, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Gritstone bio, Inc. (GRTS) stock price is $0.03. The stock is traded on NASDAQ under the ticker symbol GRTS. The 52-week range is $0.03 – $3.17.